Peptides designed for metabolic support are gaining attention for their ability to enhance fat metabolism, improve energy utilization, and support healthier body composition
Each year, an estimated 300,000 adults in the United States die of causes related to obesity [2] According to the guidelines of the National Institute of Health (NIH) regarding the treatment of obesity, weight loss drugs approved by the FDA [US Food and Drug Administration] may only be used as part of a comprehensive weight loss program, including dietary therapy and physical activity, for patients with a BMI [body mass index] of 30 with no concomitant obesity-related risk factors or diseases, and for patients with a BMI of 27 with concomitant obesity-related risk factors or diseases[3].The risk factors and diseases considered important enough to warrant pharmacotherapy at a BMI of 27--29.9 are hypertension, dyslipidemia, coronary heart disease (CHD), type 2 diabetes, and sleep apnea [3]
Interestingly, the weight loss effect of AOD-9604 did not follow the usual "more is better" principle
Dispelling Lipo B Injections Myths: Facts to Empower Your Decision Many myths surround Lipo B Injections
Any preparation or administration of retatrutide must occur only within an approved clinical trial, carried out by trained healthcare personnel following the trial protocol
